An MRI dye given into a vein for scans of the brain, spine, and head and neck.
Bracco's ProHance (NDA 020131, first approved 16 November 1992) is indicated for MRI to visualise "lesions with disrupted blood brain barrier and/or abnormal vascularity in the brain (intracranial lesions), spine and associated tissues" in adults and children including term neonates, and "lesions in the head and neck in adults". ATC V08CA04. Like every gadolinium-based contrast agent in the United States, its label carries a boxed warning on the risks of intrathecal use and nephrogenic systemic fibrosis, a thickening of skin and organs seen in people with severe kidney disease.
A gadolinium chelate that brightens tissue on MRI where it leaves the blood.
| Region | Year | Indication |
|---|---|---|
| US | 1992 | MRI of the brain, spine and associated tissues; MRI of the head and neck in adults · NDA 020131; Bracco |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Gadoteridol" OR ABSTRACT:"Gadoteridol" OR TITLE:"ProHance" OR ABSTRACT:"ProHance" OR TITLE:"gadoteridol" OR ABSTRACT:"gadoteridol") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Gadoteridol, not a curated reading list.
Shares Bracco (Bracco Imaging and Bracco Diagnostics), Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Bracco (Bracco Imaging and Bracco Diagnostics), Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/